EMRİ, K. A. S. Et Al. 2016. DIAGNOSTIC UTILITY OF MESOTHELIN, OSTEOPONTIN AND MEGAKARYOCYTE POTENTIATION FACTOR IN TURKISH PATIENTS WITH MALIGNANT MESOTHELIOMA. IASLC 17TH WORLD CONFERENCE .

EMRİ, K. A. S., DİKMEN, Z. G., SARINÇ ULAŞLI, S., ESENDAĞLI, D., YILMAZ, U., ŞİMŞEK ÖZEK, N., ... SEVERCAN, F.(2016). DIAGNOSTIC UTILITY OF MESOTHELIN, OSTEOPONTIN AND MEGAKARYOCYTE POTENTIATION FACTOR IN TURKISH PATIENTS WITH MALIGNANT MESOTHELIOMA . IASLC 17TH WORLD CONFERENCE

EMRİ, KAHRAMAN Et Al. "DIAGNOSTIC UTILITY OF MESOTHELIN, OSTEOPONTIN AND MEGAKARYOCYTE POTENTIATION FACTOR IN TURKISH PATIENTS WITH MALIGNANT MESOTHELIOMA," IASLC 17TH WORLD CONFERENCE, 2016

EMRİ, KAHRAMAN A. Et Al. "DIAGNOSTIC UTILITY OF MESOTHELIN, OSTEOPONTIN AND MEGAKARYOCYTE POTENTIATION FACTOR IN TURKISH PATIENTS WITH MALIGNANT MESOTHELIOMA." IASLC 17TH WORLD CONFERENCE , 2016

EMRİ, K. A. S. Et Al. (2016) . "DIAGNOSTIC UTILITY OF MESOTHELIN, OSTEOPONTIN AND MEGAKARYOCYTE POTENTIATION FACTOR IN TURKISH PATIENTS WITH MALIGNANT MESOTHELIOMA." IASLC 17TH WORLD CONFERENCE .

@conferencepaper{conferencepaper, author={KAHRAMAN AHMET SALİH EMRİ Et Al. }, title={DIAGNOSTIC UTILITY OF MESOTHELIN, OSTEOPONTIN AND MEGAKARYOCYTE POTENTIATION FACTOR IN TURKISH PATIENTS WITH MALIGNANT MESOTHELIOMA}, congress name={IASLC 17TH WORLD CONFERENCE}, city={}, country={}, year={2016}}